As a widely used antibiotics, there are a number of errors in the use, which may affect the efficacy of the treatment and even cause adverse reactions. The following is a detailed description of the common error areas in the use of Archicin.
i. Use of drugs to indicate faulty areas, error zones: Achicin as a panacea. Many patients who have symptoms such as cold, cough or throat pain take their own Achmycin, and believe that they can treat various inflammations. However, Achicin is primarily effective for specific bacterial infections, such as those caused by pneumonia, chlamydia, etc., and does not treat viral infections (e.g. common flu, influenza) and non-infective inflammations (e.g. allergies). Correct practice: Before the use of Achicillin, a medical diagnosis should be made clearly and clearly, identifying the infection caused by the Achicillin sensitive bacteria, before being prescribed by a doctor on the basis of the condition. Symptoms alone cannot be used blindly to prevent delays or the abuse of antibiotics.
Misuse zone, error zone: randomly adjusted dose and treatment. Some patients, in pursuit of a rapid cure, increase their own doses of Achmycin, while others, after a slight reduction in symptoms, stop their own medications and shorten the treatment process. The dose of Achicillin and the treatment process are strictly regulated and overdose use may increase the risk of adverse reactions, such as gastrointestinal reaction (e.g. nausea, vomiting, abdominal pain, etc.), hepatotoxicity, etc., while the lack of medical treatment can easily result in bacteria not being completely eliminated, causing relapse or bacterial resistance. Correct use: The use of Achicillin varies according to the type of infection and the individual circumstances of the patient. In general, for adult communities, the first day of the first day is given a 500mg uniform and the second – five days of 250mg a day; for children, the dose is based on weight. The course of treatment usually lasts 3-5 days, but for some specific infections it may need to be extended to 10-14 days. Patients must strictly use the medication prescribed by the doctor and must not change it.
iii. Misuse of joint medicine, error zone: use with other drugs at will. Some patients use other antibiotics or drugs on their own while taking the Achmycin, which is considered to enhance the efficacy of the treatment. For example, a combination of accecin and acne-antibiotics is used, whereas in practice, the combined use of acceleroxin not only does not increase the efficacy of treatment, but may increase the incidence of adverse reactions, but also increases the liver and kidney burden, if it is for the infection of accecin-sensitive bacteria. In addition, there may be interaction between Achcin and certain drugs (e.g., Geocoxin, Wafarin, etc.), affecting the efficacy of the drug or increasing the risk of adverse reactions. Correct practice: When joint use is required, doctors should be informed of all drugs being used, including non-prescription drugs and health products. Doctors make a comprehensive assessment of the pharmacological properties of the drug, its interactions and the patient ‘ s condition as to whether it is necessary to use it jointly and to choose the appropriate joint drug programme. For example, in the treatment of cholesterococcal infections, AchCin can be used in conjunction with proton pump inhibitors, americium, etc., but specific programmes need to be developed by doctors.
IV. Zone of error in the application of the population: disregard for the prohibition of the use of medicines by specific groups. The use of Archcinin in certain special groups requires particular care, but some patients and even some medical personnel may ignore this. For example, among children, the use of accecin is more widespread, but dose adjustments are often irregular for children with low body weight and incomplete liver and kidney functions. Among older persons, metabolism of achicin may slow down as a result of a decline in liver and kidney function, which can easily lead to drug accumulation in the body and increase the risk of adverse effects, but is sometimes not given sufficient attention. In addition, the use of Achromicin by pregnant and lactating women also needs to be weighed against, although it is relatively safe during pregnancy and lactation, but it needs to be carefully used under the guidance of a doctor. Correct treatment: For special population groups, the liver and kidney function, age, weight, etc. of the patient should be fully assessed before the medication is administered. Drugs for children need to be calculated accurately on the basis of weight and the adverse effects are closely observed; older persons should reduce the dose appropriately and strengthen monitoring; pregnant and lactating women should carefully choose whether to use acceacin and determine the appropriate dose and course of treatment after a full medical assessment of the condition and foetal/baby safety.
v. Misperception of adverse reactions, error zone: minor adverse reaction of Achcin is considered unnecessary. While AchCinin is generally more resistant, it can also trigger some adverse reactions, some of which may be serious. In addition to common gastrointestinal responses, there may be allergies (pesal rash, itching, vascular edema, etc.), cardiac disorders (e.g., sharp-reversible room speeds due to prolonged QT periods), liver toxicity, etc. In some cases, patients continue to insist on medication in case of minor gastrointestinal inaccuracies, and failure to provide timely feedback to doctors may lead to an increase in adverse reactions. Correct perception: During the use of AchCycin, the patient should pay close attention to his/her state of health and, in case of any symptoms of discomfort, inform the doctor in a timely manner. Doctors should also provide patients with detailed information on possible adverse reactions and responses in order to enable them to deal with or adjust their treatment in a timely manner when problems arise.
In short, the proper use of Archicin is crucial. Doctors and patients need to be better informed about drug use, usage, joint drug use care, the characteristics of the applicable population and adverse reactions, so as to avoid being caught in the wrong zone of use and to ensure that the use of AchCin is safe and effective.
